您的位置: 首页 > 农业专利 > 详情页

Physiological pharmacokinetic analysis for combined molecular MRI and dynamic PET imaging
专利权人:
Dragos-Nicolae Peligrad
发明人:
Dragos-Nicolae Peligrad
申请号:
US13000382
公开号:
US08934959B2
申请日:
2009.06.22
申请国别(地区):
US
年份:
2015
代理人:
摘要:
Magnetic resonance (MR) imaging typically has excellent spatial resolution, but relatively poor temporal resolution. In contrast, positron emission tomography (PET) typically has excellent temporal resolution, but poor spatial resolution relative to MR. Resultantly, it is advantageous to use combined PET-MR imaging sequences to create hybrid or enhanced images that reap the benefits of both modalities. A contrast agent (80) that includes both a PET tracer (82) and MR contrast enhancement (86) can be used in such a combined modality setting. The contrast agent (80) also includes a targeting system (84) that allows the contrast agent (80) to pool in a region of interest.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充